{{Rsnum
|rsid=12907866
|Gene=CYP19A1
|Chromosome=15
|position=51253257
|Orientation=plus
|GMAF=0.337
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=CYP19A1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 26.5 | 45.1 | 28.3
| HCB | 32.8 | 45.3 | 21.9
| JPT | 40.7 | 43.4 | 15.9
| YRI | 85.0 | 14.3 | 0.7
| ASW | 78.9 | 19.3 | 1.8
| CHB | 32.8 | 45.3 | 21.9
| CHD | 34.9 | 43.1 | 22.0
| GIH | 48.5 | 38.6 | 12.9
| LWK | 83.6 | 12.7 | 3.6
| MEX | 44.8 | 50.0 | 5.2
| MKK | 64.1 | 32.1 | 3.8
| TSI | 44.1 | 41.2 | 14.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=19478482
|Title=Genetic variation of CYP19 (aromatase) gene influences age at onset of Alzheimer's disease in women
}}

{{PMID Auto
|PMID=18199708
|Title=Haplotype analyses of CYP19A1 gene variants and breast cancer risk: results from the Shanghai Breast Cancer Study.
|OA=1
}}

{{PMID Auto
|PMID=18603647
|Title=Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response.
|OA=1
}}

{{PMID Auto
|PMID=18622258
|Title=Association of genetic polymorphisms in CYP19A1 and blood levels of sex hormones among postmenopausal Chinese women.
|OA=1
}}

{{PMID Auto GWAS
  |PMID=23599027
  |Trait=Menarche (age at onset)
  |Title=Genome-wide association study of age at menarche in African-American women.
  |RiskAllele=A
  |Pval=4E-7
  |OR=6.06
  |ORtxt=[3.71-8.41] unit increase
  }}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}